Frontiers in Oncology | Thoracic Oncology

Original Research

Published on 26 Mar 2021

Prognostic Impact of PCK1 Protein Kinase Activity-Dependent Nuclear SREBP1 Activation in Non-Small-Cell Lung Carcinoma

in Thoracic Oncology

Fei Shao
Xueli Bian
Juhong Wang
Daqian Xu
Wei Guo
Hongfei Jiang
Gaoxiang Zhao
Lei Zhu
Shuai Wang
Dongming Xing

Frontiers in Oncology

doi 10.3389/fonc.2021.561247

5,198 views
17 citations

Original Research

Published on 25 Mar 2021

Comprehensive Comparison Between Adjuvant Targeted Therapy and Chemotherapy for EGFR-Mutant NSCLC Patients: A Cost-Effectiveness Analysis

in Thoracic Oncology

Wenqian Li
Hanfei Guo
Lingyu Li
Jiuwei Cui

Frontiers in Oncology

doi 10.3389/fonc.2021.619376

4,486 views
5 citations

Original Research

Published on 25 Mar 2021

Dynamic cfDNA Analysis by NGS in EGFR T790M-Positive Advanced NSCLC Patients Failed to the First-Generation EGFR-TKIs

in Thoracic Oncology

Li Ma
Haoyang Li
Dongpo Wang
Ying Hu
Mengjun Yu
Quan Zhang
Na Qin
Xinyong Zhang
Xi Li
Hui Zhang

Frontiers in Oncology

doi 10.3389/fonc.2021.643199

5,342 views
14 citations

Original Research

Published on 24 Mar 2021

Optimal Surgery Type and Adjuvant Therapy for T1N0M0 Lung Large Cell Neuroendocrine Carcinoma

in Thoracic Oncology

Kunwei Peng
Huijiao Cao
Yafei You
Wenzhuo He
Chang Jiang
Lei Wang
Yanan Jin
Liangping Xia

Frontiers in Oncology

doi 10.3389/fonc.2021.591823

3,053 views
8 citations

Original Research

Published on 23 Mar 2021

Immune-Related Adverse Events Are Associated With Clinical Benefit in Patients With Non-Small-Cell Lung Cancer Treated With Immunotherapy Plus Chemotherapy: A Retrospective Study

in Thoracic Oncology

Kenji Morimoto
Tadaaki Yamada
Chieko Takumi
Yuri Ogura
Takayuki Takeda
Keisuke Onoi
Yusuke Chihara
Ryusuke Taniguchi
Takahiro Yamada
Osamu Hiranuma

Frontiers in Oncology

doi 10.3389/fonc.2021.630136

5,647 views
30 citations

Original Research

Published on 22 Mar 2021

Prognostic Implication of the Expression Level of PECAM-1 in Non-small Cell Lung Cancer

in Thoracic Oncology

Shuhui Cao
Yue Wang
Jingwen Li
Xuxinyi Ling
Yao Zhang
Yan Zhou
Hua Zhong

Frontiers in Oncology

doi 10.3389/fonc.2021.587744

6,511 views
10 citations

Original Research

Published on 22 Mar 2021

P14/ARF-Positive Malignant Pleural Mesothelioma: A Phenotype With Distinct Immune Microenvironment

in Thoracic Oncology

Federica Pezzuto
Francesca Lunardi
Luca Vedovelli
Francesco Fortarezza
Loredana Urso
Federica Grosso
Giovanni Luca Ceresoli
Izidor Kern
Gregor Vlacic
Eleonora Faccioli

Frontiers in Oncology

doi 10.3389/fonc.2021.653497

4,104 views
10 citations

Original Research

Published on 22 Mar 2021

Treatment Outcomes of 9,994 Patients With Extensive-Disease Small-Cell Lung Cancer From a Retrospective Nationwide Population-Based Cohort in the Korean HIRA Database

in Thoracic Oncology

Jung Soo Lee
Seoree Kim
Soo-Yoon Sung
Yeo Hyung Kim
Hyun Woo Lee
Ji Hyung Hong
Yoon Ho Ko

Frontiers in Oncology

doi 10.3389/fonc.2021.546672

4,177 views
5 citations

Original Research

Published on 22 Mar 2021

Detection of EGFR Mutations in Cerebrospinal Fluid of EGFR-Mutant Lung Adenocarcinoma With Brain Metastases

in Thoracic Oncology

Liang Shi
Junfang Tang
Hong Tao
Lili Guo
Weihua Wu
Hongbo Wu
Zichen Liu
Li Tong
Wei Wu
Hongxia Li

Frontiers in Oncology

doi 10.3389/fonc.2021.622142

3,248 views
7 citations

Original Research

Published on 22 Mar 2021

Bronchial Washing Fluid Versus Plasma and Bronchoscopy Biopsy Samples for Detecting Epidermal Growth Factor Receptor Mutation Status in Lung Cancer

in Thoracic Oncology

Xinyu Zhang
Chun Li
Maosong Ye
Qin Hu
Jie Hu
Ziying Gong
Jieyi Li
Xiaokai Zhao
Yiqing Xu
Daoyun Zhang

Frontiers in Oncology

doi 10.3389/fonc.2021.602402

4,556 views
7 citations

Case Report

Published on 18 Mar 2021

Case Report: Efficacy of Pyrotinib in ERBB2 Amplification Pulmonary Adenoid Cystic Carcinoma

in Thoracic Oncology

Zhongben Tang
Feng Lin
Jiarong Xiao
Xiaojun Du
Jian Zhang
Sini Li
Gongshun Tang
Chen Chen
Jian Li

Frontiers in Oncology

doi 10.3389/fonc.2021.605658

2,612 views
6 citations

Original Research

Published on 16 Mar 2021

Peripheral Blood Autoantibodies Against to Tumor-Associated Antigen Predict Clinical Outcome to Immune Checkpoint Inhibitor-Based Treatment in Advanced Non-Small Cell Lung Cancer

in Thoracic Oncology

Juan Zhou
Jing Zhao
Qingzhu Jia
Qian Chu
Fei Zhou
Xiangling Chu
Wencheng Zhao
Shengxiang Ren
Caicun Zhou
Chunxia Su

Frontiers in Oncology

doi 10.3389/fonc.2021.625578

5,041 views
21 citations

Original Research

Published on 15 Mar 2021

Efficacy and Safety of Anti-PD-1 Plus Anlotinib in Patients With Advanced Non–Small-Cell Lung Cancer After Previous Systemic Treatment Failure—A Retrospective Study

in Thoracic Oncology

Peiliang Wang
Xiaozhuang Fang
Tianwen Yin
Hairong Tian
Jinming Yu
Feifei Teng

Frontiers in Oncology

doi 10.3389/fonc.2021.628124

11,717 views
65 citations

Original Research

Published on 15 Mar 2021

Efficacy and Feasibility of Programmed Death-1/Programmed Death Ligand-1 Blockade Therapy in Non-Small Cell Lung Cancer Patients With High Antinuclear Antibody Titers

in Thoracic Oncology

Atsuto Mouri
Kyoichi Kaira
Ou Yamaguchi
Kosuke Hashimoto
Yu Miura
Ayako Shiono
Shun Shinomiya
Tomoe Akagami
Hisao Imai
Kunihiko Kobayashi

Frontiers in Oncology

doi 10.3389/fonc.2021.610952

3,670 views
11 citations

Original Research

Published on 11 Mar 2021

Patients With Short PFS to EGFR-TKIs Predicted Better Response to Subsequent Anti-PD-1/PD-L1 Based Immunotherapy in EGFR Common Mutation NSCLC

in Thoracic Oncology

Sangtian Liu
Fengying Wu
Xuefei Li
Chao Zhao
Yijun Jia
Keyi Jia
Ruoshuang Han
Meng Qiao
Wei Li
Jia Yu

Frontiers in Oncology

doi 10.3389/fonc.2021.639947

11,031 views
32 citations

Original Research

Published on 11 Mar 2021

Circulating Genetically Abnormal Cells Add Non-Invasive Diagnosis Value to Discriminate Lung Cancer in Patients With Pulmonary Nodules ≤10 mm

in Thoracic Oncology

Maosong Ye
Xiaoxuan Zheng
Xin Ye
Juncheng Zhang
Chuoji Huang
Zilong Liu
Meng Huang
Xianjun Fan
Yanci Chen
Botao Xiao

Frontiers in Oncology

doi 10.3389/fonc.2021.638223

3,739 views
16 citations